Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...
"And of course it's smarter than us. Of course, it can do things we can't, but also who really cares? I think it's only weird ...
OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...
Trump announced Tuesday that OpenAI, Softbank and Oracle would join forces to create Stargate, a new company investing $500 ...
In the age of AI, the ability to ask great questions is becoming more valuable than simply memorizing facts, says OpenAI CEO Sam Altman. Speaking on Adam Grant’s ReThinking podcast, Altman emphasized ...